Charts of the Day: Allergen, Vail Resorts, Johnson & Johnson

Carl Icahn acquired a small stake in Allergen; Vail Resorts revenue beat forecasts with quarterly earnings of $6.17 per share; Johnson & Johnson received $2.7B offer from Fortive Corp to acquire sterilization products

What to read next